Is the new PH classification useful to assess the need for heart transplantation? Looking for harder markers for hard patients.

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Andrea Moretta

Santa Maria della Scaletta Hospital Azienda USL of Imola, Imola (Italy)

9 More presentations in this session

Presentation thumbnail

Risk predictors of cardiac allograft vasculopathy after heart transplantation: Results from the United States Organ Procurement and Transplantation Network

Doctor N. Becher (Hamburg, DE)

Abstract Slides

Presentation thumbnail

Pregnancy outcomes in women with cardiothoracic transplants: a systematic review and meta-analysis

Ms S. Dong (Toronto, CA)

Abstract Slides

Presentation thumbnail

RAAS inhibition improves event-free survival in cardiac transplant recipients: results of the prospective cohort study

Professor A. Shevchenko (Moscow, RU)

Abstract Slides

Presentation thumbnail

Left- versus Bi- Ventricular Assist Device-mediated anti-HLA alloantibody induction in bridge-to-transplantation patients

Doctor I. Armenis (Nicosia, CY)

Presentation thumbnail

Effects of chronic heart failure unconventional therapies on endothelial function

Doctor M. Cipriani (Palermo, IT)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 7 - Stage D Heart Failure

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

HFA Eugene Braunwald Lecture

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Presentation

Coronary microvascular dysfunction in heart failure: observations from the MICRO registry

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources